Artivion (AORT) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.96% |
| Dec 31, 2025 | 41.03% |
| Sep 30, 2025 | 28.10% |
| Jun 30, 2025 | 44.80% |
| Mar 31, 2025 | 30.65% |
| Dec 31, 2024 | 17.13% |
| Sep 30, 2024 | -1.39% |
| Jun 30, 2024 | 0.02% |
| Mar 31, 2024 | 62.92% |
| Dec 31, 2023 | 19.16% |
| Sep 30, 2023 | -17.81% |
| Jun 30, 2023 | 7.26% |
| Mar 31, 2023 | -2.04% |
| Dec 31, 2022 | 87.51% |
| Sep 30, 2022 | -47.38% |
| Jun 30, 2022 | -1.05% |
| Mar 31, 2022 | -8.48% |
| Dec 31, 2021 | 1.88% |
| Sep 30, 2021 | 21.81% |
| Jun 30, 2021 | -22.01% |
| Mar 31, 2021 | -26.31% |
| Dec 31, 2020 | -16.92% |
| Sep 30, 2020 | 7.53% |
| Jun 30, 2020 | -33.25% |
| Mar 31, 2020 | 5.25% |
| Dec 31, 2019 | -54.69% |
| Sep 30, 2019 | 9.30% |
| Jun 30, 2019 | 23.95% |
| Mar 31, 2019 | 5.39% |
| Dec 31, 2018 | -25.44% |
| Sep 30, 2018 | 0.23% |
| Jun 30, 2018 | 13.97% |
| Mar 31, 2018 | -25.02% |
| Dec 31, 2017 | -15.93% |
| Sep 30, 2017 | -22.41% |
| Jun 30, 2017 | -3.86% |
| Mar 31, 2017 | 9.36% |
| Dec 31, 2016 | -49.64% |
| Sep 30, 2016 | 22.09% |
| Jun 30, 2016 | 20.30% |
| Mar 31, 2016 | 31.91% |
| Dec 31, 2015 | 17.99% |
| Sep 30, 2015 | 23.16% |
| Jun 30, 2015 | -16.61% |